Pressmeddelande -
Delphi advisor to Immunicum in connection with rights and directed issue
Advokatfirman Delphi has acted as legal advisor to Immunicum AB in connection with a rights issue and directed issue of approximately SEK 350 million. The share issues allow for further investments in order to enable Immunicum's clinical development programs to reach several well-defined and potentially value-creating milestones. In addition, the ownership is strengthened with reputable institutional investors, including the Fourth AP Fund, Gladiator, the Second AP Fund, Alfred Berg, Nordic Cross and Adrigo.
Immunicum is a biopharmaceutical company that develops immune therapies against a range of solid tumors. Immunicum’s approach allows for an off-the-shelf product, based on a type of immune cell called dendritic cells that are designed to stimulate a personalized anti-tumor immune response in each patient.
Erik Penser Bank has acted as financial advisor in connection with the issue.
Delphi’s team consisted of Mats Dahlberg as responsible partner, assisted by Jenny Lindén, Clara Jarbrand and Fredrik Nykvist.
Ämnen
Kategorier
Regioner
Delphi is one of the top commercial law firms in Sweden. We help our clients with mergers and acquisitions. We advise them on matters of banking, finance and capital markets. We represent clients in court and in arbitration and are acknowledged as being extremely competent in public procurement, environmental law and real estate law.
Many of us are specialists in high-tech fields such as IT, intellectual property and life science. Our drive and our interest in technology and business probably explain, in part, our success. We are often praised for our commercial sense and our ability to understand the client’s business.
Our clients are to be found primarily in Scandinavia, Europe and North America. We also co-operate with law firms globally and regularly assist clients on international matters. We have a total workforce of approximately 185, of which more than 120 are lawyers. We have offices in Stockholm, Göteborg, Malmö, Linköping and Norrköping.
